NL-OMON51489招募中2 期
Glycocalyx restoration in chronic heart failure: a proof of concept, randomized, double-blind, placebo-controlled study - Endocalyx for heart failure (GLYCO-HF)
Amsterdam UMC0 个研究点目标入组 64 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Chronic heart failure with reduced ejection fraction (HFrEF)
- •- Elevated NT-proBNP and signs of congestion (e.g. use of diuretics, peripheral
- •- Stable diuretic and antihypertensive treatment
排除标准
- •Estimated glomerular filtration rate (eGFR) <15 ml/min/1.73m2
- •- Systolic (<105 mmHg) or diastolic hypotension (<60 mmHg)
- •- A cardiovascular event in the last 3 months.
- •- Hospitalization for heart failure in the past 3 weeks or major surgery in the
- •previous 4 weeks.
研究者
相似试验
进行中（未招募）
2 期
Endocalyx for Heart FailureChronic Heart FailureNCT05966415Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)64
进行中（未招募）
1 期
Research study aiming at investigating the potential effectiveness and safety of a treatment for chronic advanced heart failure of ischemic origin. The treatment is based on patient own stem cells that will be collected and guided to the cardiac cells lineage before being injected into the heart muscle.Chronic advanced symptomatic heart failure secondary to ischemic cardiomyopathyMedDRA version: 18.1 Level: LLT Classification code 10010684 Term: Congestive heart failure System Organ Class: 100000004849EUCTR2011-001117-13-ESCelyad SA240
进行中（未招募）
不适用
Research study aiming at investigating the potential effectiveness and safety of a treatment for chronic advanced heart failure of ischemic origin. The treatment is based on patient own stem cells that will be collected and guided to the cardiac cells lineage before being injected into the heart muscle.EUCTR2011-001117-13-EECardio3 BioSciences SA240
已完成
不适用
Heart failure revascularisatioHeart failure with left ventricular systolic dysfunctionCirculatory SystemISRCTN86284615Medical Research Council (MRC) (UK)800
尚未招募
2 期
Sulodexide for chronic heart failure: a proof of concept, randomized, open-label, placebo-controlled studyheart failureNL-OMON49874Academisch Medisch Centrum64